Programmed cell death (PCD), best exemplified by apoptosis, is a genetically programmed process of cellular destruction that is indispensable for normal development and homeostasis of multicellular organisms. Tumor necrosis factor a (TNF) and related cytokines are employed by host defenses to eliminate virally infected cells through induction of apoptosis. Many viruses have evolved specific gene products to modulate this process. We have recently shown that the bovine papillomavirus type 1 (BPV-1) E6 and E7 genes independently sensitize mouse cells to TNF-induced apoptosis. In this report, we investigated the effect of E6 and E7 expression on Fasmediated apoptosis. In contrast to TNF-mediated apoptosis, E6 and E7 demonstrated opposite effects: while E7 potentiated apoptosis triggered by an agonistic Fas antibody, E6 attenuated the effect. The mitochondrial pathway leading to the activation of caspases appears to be involved in Fas-mediated apoptosis in C127 cells. To further explore the mechanisms by which E6 and E7 modulate Fas-mediated apoptosis, we examined the surface expression of Fas in cells expressing E6 and E7. Significantly, levels of surface Fas expression correlated with the opposing effects of E6 and E7 on Fas-mediated apoptosis. Specifically, while E7 increased the surface expression of Fas, E6 reduced surface Fas expression. Mutational analysis demonstrated a correlation of E6's ability to downregulate surface Fas expression and apoptosis. Since the tumor suppressor p53 can be targeted for degradation by human papillomavirus and has been shown to induce apoptosis by upregulating surface Fas expression, we investigated the role of p53 in BPV-1 E6 and E7 modulation of Fas-mediated apoptosis. Our results demonstrated that the modulatory effects by E6 and E7 could occur in the absence of p53. Interestingly, the reduced Fas protein level on the cell surface is not accompanied by a decrease in total Fas levels in E6-expressing cells. Instead, considerably more Fas protein is found in the cytoplasm of cells expressing E6. These results highlight a novel activity of E6 and E7 that may be involved in viral pathogenesis.
Introduction
Papillomaviruses are small DNA tumor viruses that infect stratifying epithelial tissues and cause warts. Specific types of human papillomaviruses (HPV), termed 'high-risk' types, infect the mucosa of human anogenital tract and are strongly associated with the development of cervical carcinoma (for a review, see zur Hausen, 2000) . Some animal papillomaviruses, such as bovine papillomavirus type 1 (BPV-1), induce the formation of skin fibropapillomas consisting of proliferating dermal fibroblasts as well as epidermal keratinocytes. Owing to its transformation and replication ability in established murine cell lines, BPV-1 has served as the prototype for studies of the molecular biology of the papillomaviruses (for a review, see Howley, 1996) .
BPV-1 efficiently induces focus formation on immortalized murine cell lines, of which C127 cells are most efficiently transformed . C127 cells transformed with BPV-1 can give rise to fibrosarcomas in animals (Schiller et al., 1984) . The transforming ability of BPV-1 primarily resides in two genes, E5 and E6. Each of these oncogenes is sufficient to induce anchorage-independent growth and focus formation on C127 cells Lowy et al., 1980; Schiller et al., 1984 Schiller et al., , 1986 DiMaio et al., 1986; Groff and Lancaster, 1986; Schlegel et al., 1986) . Although progress has been made in understanding the transformation mechanism of BPV-1 E6 through recent identification of a number of potential cellular targets (Chen et al., 1995; Tong and Howley, 1997; Vande Pol et al., 1997; Tong et al., 1998; Das et al., 2000; Zimmermann et al., 2000) , the exact mechanism remains elusive. In addition to cell transformation, BPV-1 E6 stimulates transcription when targeted to a promoter (Lamberti et al., 1990) . Furthermore, we have recently demonstrated that BPV-1 E6 sensitizes mouse cells to tumor necrosis factor a (TNF)-induced apoptosis (Rapp et al., 1999) . In contrast to BPV-1 E6 and the E7 gene from high-risk HPVs, BPV-1 E7 shows no independent transformation activity. However, it was shown to be required for full transformation of C127 cells by BPV-1 (Neary and DiMaio, 1989) . We have recently identified novel functions of BPV-1 E7 in induction of cell proliferation and sensitizing cells to TNF-induced apoptosis (Liu et al., 2000a; Fan et al., 2003) .
Many viruses have been found to modulate programmed cell death (PCD) (Lockshin and Williams, 1965) , a process of cellular destruction that is indispensable for the normal development and homeostasis of multicellular organisms. PCD serves to eliminate cells that are no longer required or potentially dangerous to the survival of the organism, such as radiation damage, aberrant growth due to oncogene activation, and virally infected cells. Viral proteins may suppress or delay PCD long enough for the production of virus progeny. On the other hand, induction of PCD at late stages of infection by viruses may represent a final and important step in spreading progeny to neighboring cells. Regulation of PCD is important in terms of pathogenesis of diseases. Inappropriate occurrence of PCD results in neurodegenerative diseases and AIDS, and the failure of appropriate PCD contributes to autoimmune diseases and cancer (for a review, see Teodoro and Branton, 1997) .
PCD can occur in different forms. Apoptosis (Kerr et al., 1972) is the best-defined cell death program and is characterized by the activation of caspases, cytoplasmic shrinkage, plasma membrane blebbing, chromatin condensation, and DNA fragmentation (Strasser et al., 2000) . In contrast, necrosis, another form of PCD, has distinct morphological features. During necrosis, cells first swell, then the plasma membrane collapses, and cells are rapidly lysed (Proskuryakov et al., 2003) . Biochemical hallmarks of apoptosis such as caspase activation and DNA fragmentation are usually absent in necrotic cells. Originally, necrosis was regarded as a disordered mode of cell death but subsequent studies have demonstrated that necrosis can also occur in normal cell physiology and embryonic development in a regulated manner (Vanden Berghe et al., 2004) . In addition, there are several forms of apoptosis-like PCD, in which the chromatin condenses into less geometric shapes (Leist and Jaattela, 2001) . Cell death can also occur in the absence of chromatin condensation through necrosis-like PCD (Leist and Jaattela, 2001 ). Owing to overlap and shared signaling pathways among various PCDs, cells dying by different forms may display varying degree and combination of features (Jaattela, 2004) .
PCD can also be triggered externally once the suitable surface death receptors are ligated. The Fas (CD95/ APO-1) receptor is a member of the death receptor subfamily of the TNF receptor (TNF-R)/nerve growth factor receptor superfamily. Fas is expressed on the cell surface. Fas transduces apoptotic signals upon crosslinking with the Fas ligand (FasL), which is experimentally substituted by agonistic anti-Fas antibodies. Fas has three cysteine-rich extracellular domains and an intracellular death domain (DD) essential for signaling. FasL binding triggers trimerization of the Fas receptor and recruitment on the cytoplasmic DD of the deathinducing signaling complex (DISC), which includes the adaptor FADD and procaspase 8 as crucial physiological death effectors. Coupling of procaspase 8 to Fas results in proteolytic activation of caspase 8. Two pathways have been shown for the signal transduction downstream of caspase 8, which are used in different cell types (types I and II) (Scaffidi et al., 1998) . In type I cells, caspase 8 directly activates procaspase 3; in type II cells, caspase 8 cleaves Bid, a proapoptotic member of the Bcl-2 family Luo et al., 1998; Gross et al., 1999) . The cleaved Bid translocates to the mitochondria, cause collapse of mitochondrial membrane potential and stimulates the release of cytochrome c. Together with Apaf-1, cytochrome c activates procaspase 9. Activated caspase 9 then cleaves and activates the executioner caspase 3, an event that leads to the cleavage of other death substrates, cellular and nuclear morphological changes, and ultimately, cell death (Wang, 2001) .
Although Fas and TNF-R share a homologous DD as well as many downstream signaling components, the two pathways lead to divergent cellular responses other than death induction (for a review, see Wallach et al., 1997) . Independent of caspase-8, Fas can initiate apoptosis through caspase-10 . Through the receptor-interacting protein (RIP), Fas triggers a caspase-independent necrotic pathway (Holler et al., 2000) . Fas was also suggested to induce an alternative apoptosis pathway by recruiting Daxx and subsequent activiation of ASK1 and JNK1/2 Chang et al., 1998) . In addition, Fas can induce both apoptosis-like PCD and necrosis-like PCD (Jaattela, 2004) .
Fas is ubiquitously expressed in lymphoid and nonlymphoid tissues (e.g. epithelia) and in many primary tumors and tumor cell lines (WatanabeFukunaga et al., 1992; Leithauser et al., 1993; French et al., 1996) . FasL expression was initially thought to be limited to hematopoietic cells; it has been detected in other cell types in subsequent studies (Bellgrau et al., 1995; Griffith et al., 1995; Hahne et al., 1996; Strand et al., 1996) . Fas and FasL expressions were also detected in skin and shown to be involved in apoptosis of keratinocytes (Sayama et al., 1994; Arnold et al., 1999) . A recent study has demonstrated that FasL serves as a sensor for DNA damage caused by UV radiation and plays a pivotal role in the removal of precancerous skin cells through the Fas/FasL apoptosis pathway (Hill et al., 1999) . The Fas/FasL system is of physiological relevance, not only in the regulation and function of the immune system but also in the prevention of tumor formation. The fact that Fas-mediated apoptosis is often markedly reduced in cancer cells has led to the proposal that Fas is a tumor suppressor gene (Peng et al., 1996) .
The HPV E6 and E7 oncogenes have been demonstrated to sensitize or suppress apoptosis, depending on the stimulus and cell type (reviewed in Rapp and Chen, 1998; Finzer et al., 2002) . We have recently reported that BPV-1 E6 and E7 each sensitized TNF-induced apoptosis in C127 cells (Rapp et al., 1999; Liu et al., 2000a) . Since TNF-R and Fas receptors share a homologous DD, and the TNF/TNF-R and FasL/Fas apoptosis pathways share many components downstream of the death receptors (for a review, see Peter and Krammer, 1998), we were interested in investigating the potential modulatory effect of BPV-1 E6 and E7 on Fas-mediated apoptosis.
Results
Opposing effects of BPV-1 E6 and E7 on Fas-mediated cell death
We previously described the establishment of C127 cells expressing BPV-1 oncogenes (Rapp et al., 1999; Liu et al., 2000a) . C127 is a nontransformed clonal line (Lowy et al., 1978) derived from a mouse mammary carcinoma (Murphy et al., 1996) . Since C127 cells can be efficiently transformed by BPV-1, they are representative of the host cell of BPV-1. The cell lines established include the PURO, PBE6, PBE7, and PBE6E7, which were created by retroviral infection of C127 cells with the vector pBabe Puro, and the vectors expressing BPV-1 E6, E7, and E6 plus E7, respectively, followed by puromycin selection. Our immunoprecipitation experiments revealed very low levels of E6 and E7 proteins expressed in the corresponding stable cell lines (Rapp et al., 1999; Liu et al., 2000a) , indicating that overexpression of these proteins did not occur. To avoid the possibility of chromosomal instability due to the expression of BPV-1 oncogenes, all experiments described here were performed using cells within 12 passages.
To assess the effect of BPV-1 E6 and E7 on Fasmediated PCD, cells were treated with Jo2, a wellknown agonistic antibody (Ab) of mouse Fas used for apoptosis induction, and/or cycloheximide (CHX), a protein synthesis inhibitor that is commonly used to enhance apoptosis. Cell death was determined by flow cytometric analysis after propidium iodide (PI) staining. Little cell death was detected in these cell lines as well as the parental C127 cells when treated by CHX (Figure 1 ) or Jo2 (data not shown) alone. When Jo2 was added in the presence of CHX, nearly 20% cell death was observed with the control PURO cells (Figure 1) . Interestingly, only 3% of PBE6 cells while more than 40% PBE7 cells died after Jo2 treatment (Figure 1 ). These results demonstrate that agonistic Fas antibodytriggered cell death can be attenuated by E6 and potentiated by E7. Furthermore, BPV-1 E6 appeared to be dominant over E7 in that the PBE6E7 cells showed significant less cell death than the PBE7 cells ( Figure 1 ). The effects of BPV-1 E6 and E7 on cell death induced by Jo2 was dose dependent (data not shown). We also examined cell death by flow cytometric analysis after Annexin-V staining, which binds with high affinity to exposed phosphatidylserine in dying cells (Koopman et al., 1994) . The result of Annexin-V assay was consistent with PI staining assay in that E6 and E7 demonstrated opposing effects on Fas-mediated apoptosis: E7 potentiated cell death triggered by Fas while E6 attenuated the effect (data not shown).
Having shown that BPV-1 E6 and E7 oncogenes exhibit opposing effects on Fas-mediated cell death, we compared the effects of the BPV-1 genome to those of the individual viral genes. The BPV-1 genome includes other viral genes such as E1 and E2 that control viral replication and transcription, and these genes may also influence Fas-mediated cell death. On the other hand, the viral genome may influence E6 and E7 on Fasmediated cell death in a subtle but critical manner. For instance, E6 and E7 expression levels in the context of the viral genome may be different from those when E6 and E7 are individually expressed. To address whether the BPV-1 genome affects Fas-mediated cell death, we examined the BPV-1 genome-containing cell line ID13, which is a BPV-1 infected and -transformed C127 cell line, for susceptibility to the agonistic Fas Ab. Since the polyomavirus middle T antigen (Py MT) was shown to sensitize C127 cells to TNF-induced apoptosis, the MTexpressing C127 cell line CNm41 was included for comparison. Interestingly, the BPV-1 genome showed potent protection against Fas-mediated cell death, to an extent even greater than that of the individual E6 gene (Figure 1c ), indicating that E6 in the context of the genome is more potent or other viral genes participate in the protection. As shown in Figure 1c , Py MT also displayed a strong protective effect, suggesting that Fas inhibition is manifested by other DNA tumor viruses.
Mitochondrial pathway is involved in Fas-mediated apoptosis in C127 cells
Several assays were performed to confirm that C127 cells underwent apoptosis after anti-Fas antibody exposure. To examine caspases activation, we labeled Fas antibody-treated E6-and E7-expressing C127 cells with fluorescently labeled caspase inhibitor FAM-VAD-FMK. The inhibitor enters cell and covalently binds to a reactive cysteine residue that resides on the large subunit of the caspase heterodimer. While unbound FAM-VAD-FMK will diffuse out of the cell and be washed away, the remaining fluorescent signal is a direct measure of the number of active caspase enzymes present in the cell at the time when the reagent was added. As shown in Figure 2 , after treatment with antiFas antibody, the population of cells with higher fluorescence intensity was significantly increased (from 1.9 to 35.4%) in the control PURO cells. Consistent with what was observed in the cell viability analysis, reduced caspase activity (8.78%) as compared with the control cells was seen in PBE6 cells, while increased caspase activity (71.2%) was detected in PBE7 cells (Figure 2 ). Moreover, PBE6E7 cells showed less caspase activity (33.1%) than the PBE7 cells ( Figure 2 ). These results demonstrate a correlation of caspase activation with Fas-induced cell death in BPV-1 oncogene-expressing cells.
Opposite effects of BPV-1 E6 and E7 on Fas Y Liu et al
Bid is a proapoptotic protein whose cleavage relays an apoptotic signal from the cell surface to mitochondria Luo et al., 1998; Gross et al., 1999) . To determine the cleavage of Bid in C127 cells after the anti-Fas antibody Jo2 treatment, cell extracts from BPV-1 oncogene-expressing and control cells were subjected to Western blot analysis with an anti-Bid antibody. Our data demonstrated that proteolytic cleavage of Bid occurred in PURO and PBE7 cells but not in PBE6 cells in response to Jo2 (Figure 3) .
Since Bid is cleaved in Fas-treated PURO and BPE7 cells, we expect that these cells may lose mitochondrial membrane potential. To test this, we used the JC-1 reagent. In healthy cells, JC-1 exists as a monomer in the cytosol (green) and also accumulates as red aggregates in the mitochondria. In cells with collapsed mitochondrial membrane potential, JC-1 remains in the cytoplasm in a green fluorescent form. Accordingly, C127 cells expressing BPV-1 oncogenes were treated with antiFas antibody and labeled with JC-1. Figure 4 shows that exposure to Jo2 resulted in loss of mitochondrial membrane potential in the control PURO cells. Consistent with what was observed for cell death and Bid cleavage, this phenomenon is more evident in PBE7 cells and less in PBE6 cells. Again, coexpression of E6 and E7 reduced the mitochondrial membrane potential loss.
To assess Fas-induced DNA fragmentation in C127 cells, we compared PURO, PBE6, and PBE7 cells by flow cytometric analysis after fixation and staining with TO-PRO-3 iodide or PI. None of the cells showed any significant sub-G1 population in response to Jo2 (not shown). Similarly, we performed the Cell Death Detection ELISA assay (Roche Applied Science). This assay provides a qualitative and quantitative determination of cytoplasmic histone-associated DNA fragments resulting from DNA degradation. Consistent with what was Figure 1 Opposing effects of BPV-1 E6 and E7 genes on Fas-mediated cell death in C127 cells. (a) C127-derived cells were treated with 5 mg/ml of cycloheximide (CHX) alone or CHX plus 5 ng/ml of anti-Fas antibody Jo2. After 24 h, both floating and adherent cells were harvested for PI staining, followed by flow cytometric analysis. The peaks with lower fluorescence intensity (PI-negative) in the histograms represent basal PI staining of the live cell population, whereas the peaks with higher fluorescence intensity (PI-positive) represent dead and dying cell populations due to permeability of these cells to PI. The result of a representative experiment is shown. Opposite effects of BPV-1 E6 and E7 on Fas Y Liu et al observed with the flow cytometric analysis, no significant enrichment of oligonucleosomes released into the cytoplasm after Jo2 treatment was detected (not shown). These data indicate that Fas-induced cell death in C127 cells does not correlate with significant DNA fragmentation. It has been reported that certain cells enter apoptosis without DNA fragmentation (Yuste et al., 2001 ; and references therein). However, C127 cells exhibited the morphological changes typical of cells undergoing apoptosis such as cellular shrinking, chromosomal condensation, and formation of apoptotic bodies following Jo2 treatment (data not shown). What is more important, our results indicate that the mitochondria pathway is involved in Fas-mediated apoptosis in C127 cells.
The opposing effects of E6 and E7 on Fas-mediated apoptosis correlate with surface Fas expression Since BPV-1 E6 exerts contrasting effects on TNF-and Fas-mediated apoptosis, E6 may target distinct components of these pathways, the most upstream of which are the death receptors Fas and TNF-R. Therefore, we examined and compared surface Fas expression in these cell lines by Jo2 staining of intact cells followed by flow cytometric analysis. As shown in Figure 5 , compared to control PURO cells, PBE6 cells showed a much weaker surface Fas signal, whereas PBE7 cells showed a much stronger signal, consistent with their sensitivity to Jo2-induced apoptosis. The presence of CHX did not affect surface Fas staining (data not shown). These data indicate that BPV-1 E6 and E7 oncogenes regulate Fasmediated apoptosis at least in part through modulation of surface Fas expression.
Mutational analysis of BPV-1 E6 modulation of apoptosis and Fas expression
With a panel of well characterized BPV-1 E6 mutants (Table 1) , we next examined whether the ability of E6 to attenuate Fas-mediated apoptosis correlates with its known activities, such as transformation, transactivation, sensitization to TNF-induced apoptosis, and interaction with cellular proteins. Characterization of this set of E6 mutants in our previous study separated the TNF sensitization function of E6 from its transformation and transactivation functions (Liu et al., 2002) . Given the mounting evidence on the association of loss of the Fas/FasL apoptosis system and development of cancer, we were interested in the possible connection between E6 protection against Fas-mediated apoptosis and transformation of C127 cells. As shown in Figure 6a , cells expressing E6 mutants displayed varying susceptibility to the agonistic Fas antibody Jo2. Interestingly, both the transforming competent mutant R42W and mutant 491 that possesses marginal transforming activity (1% wild-type) showed nearly wild-type protection against Fas-mediated apoptosis (Figure 6a and Table 1 ). Similarly, mutants K35E, 367, 438, and 471 that are defective for transforming C127 cells still (Figure 6a ). These data imply that protection against Fas-mediated apoptosis by BPV-1 E6 is not sufficient for transformation. Notably, mutant 359 that is defective for all of the known functions of E6 (Table 1) retained substantial protection activity (Figure 6a ), indicating that the transactivation activities and association with known cellular proteins are not important for protection against Fas-mediated apoptosis either. We also determined surface Fas expression profiles in these mutant cell lines (Figure 6b ) and compared these data to susceptibility of mutant cell lines to Fas antibody as shown in Figure 6a ). The estimated correlation was 0.91 (95% confidence interval: (0.57, 0.98), P ¼ 0.0017). These results support our hypothesis that E6 attenuates Fas-mediated apoptosis through downregulation of surface Fas expression.
It remains possible that the relative effects of E6 mutants on apoptosis and Fas surface expression are due to the steady-state levels of the proteins. Therefore, we performed an immunoprecipitation experiment using antisera against BPV-1 E6 and radiolabeled cell extract. While the level of mutants K35E was similar to that of the wild-type E6, the level of R42W was slightly increased, and the other mutants were somewhat reduced (not shown). It is not clear to what extent the reduced level of mutant proteins contributes to the altered biological activities. However, at least for mutants K35E and R42W, we can rule out the possibility that their effects on apoptosis and Fas 
Modulatory effects of BPV-1 E6 and E7 on Fas-mediated apoptosis can occur in the absence of p53
Given that p53 has been suggested to upregulate surface Fas expression and consequent apoptosis (Bennett et al., 1998) , we were interested in determining whether the E6 and E7 effects were p53 dependent. C127 cells were reported to contain wild-type p53 (Murphy et al., 1996) . Unlike the high-risk HPV E6, BPV-1 E6 does not bind p53 , although it does bind the ubiquitin-protein ligase E6AP that forms a complex with high-risk HPV E6 to degrade p53 (Chen et al., 1995; Bohl et al., 2000) . To assess the role of p53 in BPV-1 oncogenes-modulated apoptosis, we established stable cell lines expressing BPV-1 E7 (10.1 PBE7), and E6 plus E7 (10.1 PBE6E7) in the p53À/À mouse fibroblast cell line 10.1 (Murphy et al., 1996) . The 10.1 cells expressing the retroviral vector (10.1 PURO) and BPV-1 E6 (10.1 PBE6) were described previously (Rapp et al., 1999) . We compared these cell lines for susceptibility to Jo2 treatment. Similar to what was observed in C127-derived cells, the opposing effects of E6 and E7 on Fas-mediated cell death were also seen in 10.1 cells (Figure 7) . Coexpression of E6 and E7 exerted a greater resistance as compared to the control 10.1 PURO cells (Figure 7) . Notably, the effects of E6 and E7 on Fasinduced apoptosis in p53-deficient cells are less dramatic than in C127 cells, suggesting that p53 might play a role in this process. Nevertheless, the ability of BPV E6 to inhibit apoptosis in p53-deficient cells is statistically significant (P ¼ 0.005). BPV E7-enhanced apoptosis in p53-deficient cells is also significant, although at a lower confidence level (P ¼ 0.06). E6 also significantly inhibited E7-enhanced apoptosis (P ¼ 0.0002). The surface Fas expression in 10.1 cells also correlated with the opposing effects of E6 and E7 on Fas-mediated apoptosis (data not shown). Taken together, the opposing effects of E6 and E7 on both p53 wild-type (C127) and p53-null (10.1) cells demonstrated that modulation of Fas-mediated apoptosis by E6 and E7 can occur in the absence of p53, indicating a p53-independent mechanism.
Increased total Fas protein accumulates in the cytoplasm of E6-expressing cells
To begin to understand the molecular basis by which E6 and E7 modulate surface Fas expression, we examined total Fas protein levels by Western blot analysis. Surprisingly, in contrast to changes in surface Fas expression, PBE6 cells exhibited significantly increased total Fas protein levels (Figure 8a) , while E7 did not show significant effect on total Fas expression (Figure 8a) . Furthermore, the E6/E7-expressing PBE6E7 cells also showed significantly increased total Fas at a level comparable to that seen with PBE6 (Figure 8a ), although reduced surface Fas expression was observed in these cells ( Figure 5 ). This observation indicates a lack of correlation between surface and total Fas expression. Given the contrasting effects of E6 on surface and total Fas expression, we decided to determine in which cellular compartment the majority of Fas was localized. For this purpose, we examined the cellular localization of Fas in these cells by indirect immunofluorescence (Figure 8b ). Our data showed significant cytoplasmic staining of Fas in PBE6 and PBE6E7 cells but not in PURO or PBE7 cells. However, the specific cellular compartment of Fas localization is inconclusive. Our attempt to colocalize Fas to Golgi or endosome/lysozome was not successful, as makers for these compartments did not work under the conditions set for the anti-mouse Fas antibodies.
Discussion
Viral genes have been implicated in both induction and suppression of apoptosis (for a review, see Teodoro and Branton, 1997) . In this study, we present evidence that BPV-1 E6 and E7 display opposing effects on Fas-mediated apoptosis: while E6 attenuates apoptosis triggered by an agonistic Fas antibody, E7 potentiates the response. We have recently shown that the BPV-1 E6 and E7 genes each sensitized mouse C127 cells to TNFinduced apoptosis (Rapp et al., 1999; Liu et al., 2000a) . Analogous to BPV-1 E6, the polyoma virus middle T antigen also sensitizes mouse C127 cells to TNF (Bergovist et al., 1997; Rapp et al., 1999) and protects these cells from Fas-mediated apoptosis (Figure 1c) . Analogous to the BPV-1 E6 and E7 genes, opposing effects on Fas-and TNF-mediated apoptosis has been observed for the adenovirus E3-10.4K/14.5K complex and E1A (Duerksen-Hughes et al., 1989; Wold and Gooding, 1989; Shisler et al., 1997) . Therefore, some viruses seem to utilize different gene products to conteract each other in response to a particular apoptotic stimulus. Obviously, viral interference with apoptosis is complicated, reflected by the balance between host defense and viral persistence, which may vary with different death-inducing signals as well as viral gene expression under a particular condition. The opposing effects of BPV-1 E6 and E7 may be implicated in the life cycle, replication, and maintenance of BPV-1. Recent studies have shown that the high-risk HPV-16 E6 and E7 oncogenes either increase or decrease apoptosis depending on the cell lines and apoptotic stimuli employed (Puthenveettil et al., 1996; Jones et al., 1997; Iglesias et al., 1998; Magal et al., 1998; Rapp and Chen, 1998; Stoppler et al., 1998; Alfandari et al., 1999; Liu et al., 2000b; Mannhardt et al., 2000; Finzer et al., 2002) . Interestingly, while normal human diploid fibroblasts that express HPV-16 E7 are highly predisposed to undergo apoptosis in response to growth factor deprivation, they have decreased propensity to undergo apoptosis in response to TNF-and Fas treatment (Jones et al., 1997; Thompson et al., 2001) . On the other hand, human keratinocytes expressing E7 were more prone to TNF-and TRAIL-mediated apoptosis (Basile et al., 2001) . A more recent report suggested that HPV-16 E6-expressing human keratinocytes were resistant to Fasinduced, E7-mediated apoptosis . Interestingly, similar to what we observed with BPV-1 E6/E7, HPV-16 E6/E7 expressing also led to a change of Fas at the cell surface, although not as dramatic . These results indicate that HPV and BPV employ similar strategies to modulate apoptosis.
Interference with Fas-mediated apoptosis by viral proteins can occur at multiple steps in the signaling pathway (for a review, see Tschopp et al., 1998) . For example, the HIV viral transcription factor Tat is able to upregulate FasL, while the Adenovirus (Ad) E3 10.4K/ 14.5K complex downregulates surface Fas expression; hepatitis-B virus reduces the expression of the adaptor protein FADD; viral FLIP proteins such as the Ad E3-14.7 K protein bind to caspase 8 and compete with caspase 8 recruitment and activation; cowpox virus CrmA also targets caspase 8, whereas baculovirus p35 and IAPs interrupt the caspase cascade further downstream (for a review, see Tschopp et al., 1998) . We investigated the effects of BPV-1 E6 and E7 genes on surface Fas expression. Consistent with the opposing effects on anti-Fas killing in C127 cells, E6 and E7 showed opposing effects on surface Fas expression ( Figure 5 ), suggesting that regulation of surface Fas expression is important for their effect on Fas-mediated apoptosis. Similar to downregulation of surface Fas expression by BPV-1 E6, the adenovirus E3-10.4K/ 14.5 K complex blocks surface Fas expression and results in resistance to Fas-mediated apoptosis (Shisler et al., 1997; Elsing and Burgert, 1998; Tollefson et al., 1998 ). These results demonstrate that different viruses may develop similar ways to modulate apoptosis.
It has been reported that p53 upregulates surface Fas expression and Fas-mediated apoptosis (Bennett et al., 1998) . HPV-16 E6 promotes p53 degradation and E7 stabilizes p53 (Scheffner et al., 1990; Boyer et al., 1996; Jones et al., 1997) . However, BPV-1 E6 neither binds p53 nor promotes p53 degradation , and BPV-1 E7 does not affect p53 stability (Liu et al., 2000a) . Despite this, we investigated the possible involvement of p53 in the Fas-modulating effects by E6 and E7. Similar to C127 (p53 þ / þ ) cells, opposing effects of E6 and E7 were observed in the p53 À/À 10.1 cells on Fas-mediated apoptosis ( Figure 7 ) and surface Fas expression (not shown), arguing for p53-independence of this phenomenon. Our previous studies showed similar p53-independence in BPV-1 E6-and E7-mediated sensitization to TNF (Rapp et al., 1999; Liu et al., 2000a) . However, since the effects of E6 and E7 on Fas-mediated cell death were reduced in p53-null cells (compare Figures 1 and 7) , we cannot rule out the possibility that p53 may contribute to some extent to these effects. The mechanism by which E6 and E7 affect surface Fas expression is not known. A recent study showed that overexpression of p53 transiently increased surface Fas expression by transport from the Golgi complex without affecting total Fas protein levels (Bennett et al., 1998) . BPV-1 E7 may use a similar mechanism to enhance Fas transport to the cell surface. The adenovirus E3-10.4K/14.5 K complex downregulates surface Fas by mediating its internalization from cell surface and destruction inside lysosomes (Tollefson et al., 1998) . As a result, the total Fas protein was significantly reduced. E6 may use a similar strategy to internalize Fas, although this is not accompanied by its degradation. Alternatively, E6 may disrupt the transport of Fas from the Golgi complex to cell surface. Interestingly, BPV-1 E6 associates with the clathrin adaptor complex AP-1 that is required for clathrin-mediated cellular transport from the trans-Golgi network (Tong et al., 1998) . It is plausible that AP-1 plays a role in E6-mediated Fas localization. However, the data that an E6 mutant (359) does not bind AP-1 yet downregulated Fas argues against this possibility (Table 1) . Regarding surface expression, C127 as well as 10.1 cells express very low levels of Fas on the cell surface, which were detectable by very sensitive flow cytometry (Figure 5a and data not shown). Confocal microscopy failed to detect surface Fas (Figure 8b ). Low-level surface Fas expression may also explain the necessity for CHX treatment in addition to the agonistic Fas antibody in triggering C127 cells to apoptosis. Further studies are required to delineate the mechanism by which E6 and E7 modulate surface Fas expression.
Materials and methods

Cell culture
Cell lines C127, 10.1, and the amphotropic retrovirus packaging cell line PA317, were cultured in DMEM plus 10% fetal calf serum. The establishment of cell lines expressing BPV-1 oncogenes was described previously (Rapp et al., 1999; Liu et al., 2000a) . The pBabe Puro-based retroviral vectors, BPV-1 E6, E7, and E6 plus E7 were introduced into PA317 cells by calcium phosphate precipitation. Puromycin-resistant colonies were pooled and the supernatant containing roughly equivalent titer of virus was used to infect C127 and 10.1 cells, respectively. Following retrovirus infection, colonies of infected cells were selected for puromycin resistance, pooled and expanded as stable cell lines. The C127-derived cell lines were designated PURO, PBE6, PBE7, and PBE6E7, respectively; and the 10.1-derived ones 10.1 PURO, 10.1 PBE6, 10.1 PBE7, and 10.1 PBE6E7, respectively. The BPV-1-transformed ID13 cell line and the Py middle T-expressing cell line CNm41 (or MT41) are C127 derivatives previously described (Bergovist et al., 1997) .
Flow cytometric assay for cell viability
Cells were seeded in six-well plates at a density of 2 Â 10 5 cells per well. The following day, the medium was changed to media containing cycloheximide (CHX) and a hamster anti-mouse Fas antibody Jo2 (PharMingen). Following 24 h incubation, both floating and adherent cells were harvested and pelleted, stained with PI or phycoerythrin-conjugated Annexin-V, and analysed on a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA) as previously described (Liu et al., 2000a) .
Detection of active caspases and mitochondrial membrane potential
For active caspase analysis, cells treated with anti-Fas antibody and/or CHX were adjusted to a density of 10 6 cells/ ml and labeled with FAM-VAD-FMK (Immunochemistry Technologies, LLC) at 371C for an hour. Fluorescence was measured by flow cytometry on the FL1 channel. For measuring mitochondrial membrane potential, APO LOGIX JC-1 Assay Kit from Cell Technology was used. Briefly, cell suspension was adjusted to a density of 10 6 cells/ml and incubated in a medium containing 10 mg/ml JC-1 at 371C for 15 min. The cells were then washed with 1 Â assay buffer, resuspended, and analysed by FACScan flow cytometer. A minimum of 10 000 cells per sample were analysed. Data were further analysed with FlowJo software (Tree Star Inc.).
Surface Fas staining and flow cytometry
Surface Fas expression was assessed by anti-Fas antibody staining followed by flow cytometric analysis. The protocol is modified from the one described by Ogasawara et al. (1995) . Briefly, the adherent cells grown on a 100-mm culture dish were detached by trypsinization and washed twice with staining solution (PBS containing 2% fetal calf serum). One aliquot of about 10 6 cells was then incubated with an optimal concentration (0.5 mg/ml) of the primary antibody Jo2 for 30 min at 41C in 100 ml of staining solution. As the negative control, another aliquot of cells was incubated with the same volume of staining solution in the absence of the primary antibody. After washing twice with staining solution, both aliquots of cells were incubated with the secondary antibody, the FITC-conjugated mouse anti-hamster IgG (PharMingen), at 41C for 30 min. The cells were then washed twice with staining solution, suspended in 500 ml of the same solution and analysed by flow cytometry. The FITC fluorescence intensity of the primary antibody-stained cells was compared with the control cells that omitted the primary antibody, and the relative increase of fluorescence intensity was used to represent surface Fas expression.
Western blot analysis
Whole-cell extracts containing 50 mg of proteins as determined by the bicinchroninic acid (BCA) protein assay (Pierce) were fractionated on a 10% SDS-PAGE gel and blotted to a PVDF membrane. The membrane was then incubated successively with polyclonal antibodies and horse raddish peroxidaseconjugated anti IgG, followed by processing with SuperSignal Substrate (Pierce). The antibodies used in this study were against Fas (Sc-7886, Santa Cruz Biotechnology, Inc.), Bid (provided by Dr Honglin Li), and b-tubulin (Sigma T4026).
Immunofluorescence analysis
Eight-well chamber slides were used for the culture in duplicate wells of PURO, PBE6, or PBE7 cells. After one rinse in serumfree MEM and removal of the wells, slide was fixed in 100% cold ethanol at À201C for 2-3 min (all rest of the steps were carried out at room temperature). Samples were washed three times in PBS (5 min each) and incubated for 1 h containing Opposite effects of BPV-1 E6 and E7 on Fas Y Liu et al 0.05% Tween-20 (PBST) and 5% BSA. Cells were rinsed once in PBST containing 1% BSA (PBST-BSA) and incubated with PBST containing 1% BSA and rabbit anti-Fas antibodies (FL-335, Santa Cruz Biotechnology, Inc.) for at least 1 h. Samples were washed in PBST three times (5 min each) and incubated in PBST-BSA containing Cy2-conjugated Donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) for 1 h. Cells were washed with PBST, mounted, examined using a BioRad MRC1024ES confocal laser scanning microscope.
Statistic analysis
T-test has been used to assess statistical significance of differences in results from p53-deficient cells. Po0.1 was considered significant. The correlation of mean change in apoptosis and surface Fas expression was estimated across E6 mutant-expressing cells lines. Estimates and tests were carried out using Stata 8.2 (Stata Corporation, College Station, TX, USA).
